Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 18, 2017 - Issue sup1: Edaravone (MCI-186) in Amyotrophic Lateral Sclerosis (ALS). Guest Editor: Angela Genge
Submit an article Journal homepage
4,906
Views
36
CrossRef citations to date
0
Altmetric
Clinical Trial

Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation)

THE WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
Pages 40-48 | Received 27 Mar 2017, Accepted 18 Jul 2017, Published online: 05 Sep 2017

References

  • Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–700.
  • Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
  • Japan intractable diseases information center. Available at: http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000089881.pdf. Accessed February 2, 2017.
  • Atsuta N, Watanabe T, Ito M, Senda J, Sobue G. Problems of the current clinical personal clinical survey sheet in amyotrophic lateral sclerosis. Workshop of the Specified Disease Treatment Research Program. 2005. Japanese.
  • The Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, Edaravone (MCI-186), on acute brain infarction. Cerebravascuar Dis. 2003; 15:222–9.
  • Abe K, Itoyama Y, Sobue G, Tsuji S, Aoki M, Doyu M, et al. Comfirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:610–17.
  • The Edaravone (MCI-186) ALS 16 Study Group. A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(Suppl). [Epub ahead of print]. doi: 10.1080/21678421.2017.1363780.
  • The Writing Group on behalf of the Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505–12.
  • Brooks BR. Introduction defining optimal management in ALS: from first symptoms to announcement. Neurology. 1999;53:S1–S3.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13–21.
  • Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S, et al. Study of functional rating scale for amyotrophic lateral sclerosis: Revised ALSFRS (ALSFRS-R) Japanese Version. No To Shinkei. 2001;53:346–55. Japanese.
  • Norris FHJr., Calanchini PR, Fallat RJ, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology. 1974;24:721–8.
  • Oda E, Ohashi Y, Tashiro K, Mizuno Y, Kowa H, Yanagisawa N. Reliability and factorial structure of a rating scale for amyotrophic lateral sclerosis. No To Shinkei. 1996;48:999–1007. Japanese.
  • Jenkinson C, Fitzpatrick R, Brennen C, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:33–40.
  • Yamaguchi T, Ohbu S, Ito Y, Moriwaka F, Tashiro K, Ohashi Y, et al. Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis: Assessment questionnaire 40 (ALSAQ-40). No To Shinkei. 2004; 56:483–94. Japanese.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.